Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% OTC, which is the generic of Alcon’s Pataday Once Daily Relief Ophthalmic ...
The family of a 91-year-old Maine woman sued Glenmark in federal court in Newark, New Jersey, last year, alleging the company ...
Alnylam Pharma (ALNY) stock rocketed higher on Friday after the pharmaceutical company received approval from the U.S. Food and Drug ...
The FDA found concerns at a factory in India that makes generic drugs for U.S. patients including one drug that was ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration ...
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX®2 ...
The shares of Glenmark Pharmaceuticals Limited were trading at ₹1,399.35 down by ₹5.05 or 0.36 per cent on the NSE today at 10.15 am. The new product, containing 17 grams of polyethylene ...
About Glenmark Pharmaceuticals Ltd. Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics ...
MAHWAH, N.J., March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch 1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback